Name	Dosage	Strength	Route	Labeller	Marketing Start	Marketing End
Unlock Additional Data
Mega-C-sodium Inj 250mg/ml	Solution		Intravenous	Kripps Pharmacy Ltd.	1981-12-31	Not applicable
Vitamin C	Liquid	250 mg	Intramuscular; Intravenous	Sandoz Canada Incorporated	1989-12-31	Not applicable

Additional Data Available

Application Number

A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

Learn more

Product Code

A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

Learn more

Over the Counter Products

Name	Dosage	Route	Labeller	Marketing Start	Marketing End
Unlock Additional Data
C Wafer 500 Chewable 500mg	Wafer	Oral	Nu Life Nutrition Ltd.	1986-12-31	2000-05-23
Natural Fruit Chew C 250mg Tangy Orange Flavour	Tablet	Oral	Natural Factors Nutritional Products Ltd.	2001-01-01	2009-09-28
Sodium Ascor Crystal 888.8mg/gm USP	Powder	Oral	Vita Health Products Inc	1996-10-11	2002-07-31
Tgi Tab 50mg	Tablet	Oral	Seroyal International Inc.	1980-12-31	1996-09-10
Vitamin C 60mg	Tablet	Oral	Wn Pharmaceuticals Ltd.	1999-04-09	2008-07-17

Additional Data Available

Application Number

A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

Learn more

Product Code

A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

Learn more

Mixture Products

Name	Ingredients	Dosage	Route	Labeller	Marketing Start	Marketing End
Animal Shaped Chew Vit C Tab 250mg	Sodium ascorbate (159 mg) + Ascorbic acid (110 mg)	Tablet	Oral	Hall Laboratories, Ltd.	1982-12-31	2003-09-11
Appedrine	Sodium ascorbate (10 mg) + Benzocaine (3 mg) + Ferrous fumarate (3.33 mg) + Nicotinamide (3.33 mg) + Riboflavin (.4 mg) + Thiamine hydrochloride (.33 mg) + Vitamin A (1333 unit) + Vitamin D (133 unit)	Tablet	Oral	Chattem, Inc.	1975-12-31	2004-07-08
Ascorbex 500 Tab	Sodium ascorbate (337.5 mg) + Ascorbic acid (200 mg)	Tablet	Oral	SantÉ Naturelle (Ag) LtÉe	1988-12-31	2004-08-05
Bugs Bunny and Friends Multiple Vitamins	Sodium ascorbate (50 mg) + Cyanocobalamin (3 mcg) + Folic acid (0.1 mg) + Nicotinamide (15 mg) + Pyridoxine hydrochloride (1 mg) + Riboflavin (1.5 mg) + Thiamine mononitrate (1.5 mg) + Vitamin A (5000 unit) + Vitamin D (400 unit)	Tablet	Oral	Bayer Inc Consumer Care	1996-12-31	2004-04-15
Bugs Bunny Chew Multi Vit Plus Iron	Sodium ascorbate (50 mg) + Cyanocobalamin (3 mcg) + Ferrous fumarate (12 mg) + Folic acid (.1 mg) + Nicotinamide (15 mg) + Pyridoxine hydrochloride (1 mg) + Riboflavin (1.5 mg) + Thiamine mononitrate (1.5 mg) + Vitamin A acetate (5000 unit) + Vitamin D (400 unit)	Tablet	Oral	Miles Inc. Pharmaceutical Division	1983-12-31	1996-09-09
Chewable Multiple Vitamins for Children	Sodium ascorbate (50 mg) + Cyanocobalamin (3 mcg) + Folic acid (.1 mg) + Nicotinamide (15 mg) + Pyridoxine hydrochloride (1 mg) + Riboflavin (1.5 mg) + Thiamine mononitrate (1.5 mg) + Vitamin A acetate (5000 unit) + Vitamin D (400 unit)	Tablet	Oral	Randle Pharmaceutical Inc.	1996-09-19	1999-09-03
Chewable Multivitamins	Sodium ascorbate (50 mg) + Cholecalciferol (400 unit) + Cyanocobalamin (3 mcg) + Folic acid (0.1 mg) + Nicotinamide (15 mg) + Pyridoxine hydrochloride (1 mg) + Riboflavin (1.5 mg) + Thiamine mononitrate (1.5 mg) + Vitamin A (5000 unit)	Tablet	Oral	Wn Pharmaceuticals Ltd.	2002-05-31	2008-07-17
Chewable Multivitamins Plus Iron	Sodium ascorbate (50 mg) + Cholecalciferol (400 unit) + Cyanocobalamin (3 mcg) + Ferrous fumarate (4 mg) + Folic acid (0.1 mg) + Nicotinamide (15 mg) + Pyridoxine hydrochloride (1 mg) + Riboflavin (1.5 mg) + Thiamine mononitrate (1.5 mg) + Vitamin A (5000 unit)	Tablet	Oral	Wn Pharmaceuticals Ltd.	2002-05-31	2007-08-07
Chewable Vit C 100mg	Sodium ascorbate (50 mg) + Ascorbic acid (50 mg)	Tablet	Oral	Bioforce Canada Inc.	1994-12-31	1997-04-04
Chewable Vitamin C 100mg - Tab	Sodium ascorbate (79 mg) + Ascorbic acid (30 mg)	Tablet	Oral	Vita Health Products Inc	1996-10-18	2002-07-31

Unapproved/Other Products

Name	Ingredients	Dosage	Route	Labeller	Marketing Start	Marketing End
Centratex	Sodium ascorbate (200 mg/1) + Cupric sulfate (0.8 mg/1) + Cyanocobalamin (15 ug/1) + Folic acid (1 mg/1) + Iron (106 mg/1) + Magnesium sulfate (6.9 mg/1) + Manganese sulfate (1.3 mg/1) + Nicotinamide (30 mg/1) + Calcium pantothenate (10 mg/1) + Pyridoxine hydrochloride (5 mg/1) + Riboflavin (6 mg/1) + Thiamine mononitrate (10 mg/1) + Zinc sulfate, unspecified form (18.2 mg/1)	Capsule	Oral	Centurion Labs, LLC	2009-06-14	Not applicable
Irospan 24/6	Sodium ascorbate (100 mg/1) + Sodium ascorbate (100 mg/1) + Biotin (300 ug/1) + Biotin (300 ug/1) + Calcium carbonate (100 mg/1) + Cyanocobalamin (10 ug/1) + Cyanocobalamin (10 ug/1) + Ferrous bisglycinate (65 mg/1) + Folic acid (1 mg/1) + Folic acid (1 mg/1) + Calcium formate (155 mg/1) + Iron Dextran (65 mg/1) + Niacin (25 mg/1) + Niacin (25 mg/1) + Calcium pantothenate (300 ug/1) + Calcium pantothenate (7 mg/1) + Pyridoxine hydrochloride (30 mg/1) + Pyridoxine hydrochloride (30 mg/1) + Riboflavin sodium (5 mg/1) + Riboflavin (5 mg/1) + Succinic acid (150 mg/1) + Thiamine hydrochloride (5 mg/1) + Thiamine hydrochloride (5 mg/1)		Oral	WOMENS CHOICE PHARMACEUTICALS LLC	2011-04-15	Not applicable
Irospan 24/6	Sodium ascorbate (100 mg/1) + Sodium ascorbate (100 mg/1) + Biotin (300 ug/1) + Biotin (300 ug/1) + Calcium carbonate (100 mg/1) + Cyanocobalamin (10 ug/1) + Cyanocobalamin (10 ug/1) + Ferrous bisglycinate (65 mg/1) + Folic acid (1 mg/1) + Folic acid (1 mg/1) + Calcium formate (155 mg/1) + Iron Dextran (65 mg/1) + Niacin (25 mg/1) + Niacin (25 mg/1) + Calcium pantothenate (300 ug/1) + Calcium pantothenate (7 mg/1) + Pyridoxine hydrochloride (30 mg/1) + Pyridoxine hydrochloride (30 mg/1) + Riboflavin sodium (5 mg/1) + Riboflavin (5 mg/1) + Succinic acid (150 mg/1) + Thiamine hydrochloride (5 mg/1) + Thiamine hydrochloride (5 mg/1)		Oral	WOMENS CHOICE PHARMACEUTICALS LLC	2011-04-15	Not applicable
Multi Vitamin with Fluoride	Sodium ascorbate (36 mg/1) + Ascorbic acid (24 mg/1) + Cholecalciferol (400 [iU]/1) + Cyanocobalamin (4.5 ug/1) + DL-alpha tocopheryl acetate (15 [iU]/1) + Folic acid (0.3 mg/1) + Nicotinamide (13.5 mg/1) + Pyridoxine hydrochloride (1.05 mg/1) + Riboflavin (1.2 mg/1) + Sodium fluoride (0.25 mg/1) + Thiamine mononitrate (1.05 mg/1) + Vitamin A acetate (2500 [iU]/1)	Tablet, chewable	Oral	Physicians Total Care, Inc.	2003-09-05	2013-01-15
Multi Vitamin with Fluoride	Sodium ascorbate (36 mg/1) + Ascorbic acid (24 mg/1) + Cholecalciferol (400 [iU]/1) + Cyanocobalamin (4.5 ug/1) + DL-alpha tocopheryl acetate (15 [iU]/1) + Folic acid (0.3 mg/1) + Nicotinamide (13.5 mg/1) + Pyridoxine hydrochloride (1.05 mg/1) + Riboflavin (1.2 mg/1) + Sodium fluoride (0.5 mg/1) + Thiamine mononitrate (1.05 mg/1) + Vitamin A acetate (2500 [iU]/1)	Tablet, chewable	Oral	A S Medication Solutions	2009-10-09	Not applicable
Multi Vitamin with Fluoride	Sodium ascorbate (36 mg/1) + Ascorbic acid (24 mg/1) + Cholecalciferol (400 [iU]/1) + Cyanocobalamin (4.5 ug/1) + DL-alpha tocopheryl acetate (15 [iU]/1) + Folic acid (0.3 mg/1) + Nicotinamide (13.5 mg/1) + Pyridoxine hydrochloride (1.05 mg/1) + Riboflavin (1.2 mg/1) + Sodium fluoride (1 mg/1) + Thiamine mononitrate (1.05 mg/1) + Vitamin A acetate (2500 [iU]/1)	Tablet, chewable	Oral	Qualitest	2009-10-09	2014-12-31
Multi Vitamin with Fluoride	Sodium ascorbate (36 mg/1) + Ascorbic acid (24 mg/1) + Cholecalciferol (400 [iU]/1) + Cyanocobalamin (4.5 ug/1) + DL-alpha tocopheryl acetate (15 [iU]/1) + Folic acid (0.3 mg/1) + Nicotinamide (13.5 mg/1) + Pyridoxine hydrochloride (1.05 mg/1) + Riboflavin (1.2 mg/1) + Sodium fluoride (0.5 mg/1) + Thiamine mononitrate (1.05 mg/1) + Vitamin A acetate (2500 [iU]/1)	Tablet, chewable	Oral	Qualitest	2009-10-09	2014-12-31
Multi Vitamin with Fluoride	Sodium ascorbate (36 mg/1) + Ascorbic acid (24 mg/1) + Cholecalciferol (400 [iU]/1) + Cyanocobalamin (4.5 ug/1) + DL-alpha tocopheryl acetate (15 [iU]/1) + Folic acid (0.3 mg/1) + Nicotinamide (13.5 mg/1) + Pyridoxine hydrochloride (1.05 mg/1) + Riboflavin (1.2 mg/1) + Sodium fluoride (0.25 mg/1) + Thiamine mononitrate (1.05 mg/1) + Vitamin A acetate (2500 [iU]/1)	Tablet, chewable	Oral	Qualitest	2009-10-09	2014-08-31
Multi Vitamin with Fluoride	Sodium ascorbate (36 mg/1) + Ascorbic acid (24 mg/1) + Cholecalciferol (400 [iU]/1) + Cyanocobalamin (4.5 ug/1) + DL-alpha tocopheryl acetate (15 [iU]/1) + Folic acid (0.3 mg/1) + Nicotinamide (13.5 mg/1) + Pyridoxine hydrochloride (1.05 mg/1) + Riboflavin (1.2 mg/1) + Sodium fluoride (1 mg/1) + Thiamine mononitrate (1.05 mg/1) + Vitamin A acetate (2500 [iU]/1)	Tablet, chewable	Oral	Physicians Total Care, Inc.	2003-06-04	2013-01-15
Multi Vitamin with Fluoride	Sodium ascorbate (36 mg/1) + Ascorbic acid (24 mg/1) + Cholecalciferol (400 [iU]/1) + Cyanocobalamin (4.5 ug/1) + DL-alpha tocopheryl acetate (15 [iU]/1) + Folic acid (0.3 mg/1) + Nicotinamide (13.5 mg/1) + Pyridoxine hydrochloride (1.05 mg/1) + Riboflavin (1.2 mg/1) + Sodium fluoride (0.5 mg/1) + Thiamine mononitrate (1.05 mg/1) + Vitamin A acetate (2500 [iU]/1)	Tablet, chewable	Oral	Physicians Total Care, Inc.	2003-09-08	2013-01-15

Categories

UNII

S033EH8359

CAS number

134-03-2

Weight

Average: 198.106
Monoisotopic: 198.01403223

Chemical Formula

C₆H₇NaO₆

InChI Key

PPASLZSBLFJQEF-RXSVEWSESA-M

InChI

InChI=1S/C6H8O6.Na/c7-1-2(8)5-3(9)4(10)6(11)12-5;/h2,5,7-10H,1H2;/q;+1/p-1/t2-,5+;/m0./s1

IUPAC Name

sodium (2R)-2-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2,5-dihydrofuran-3-olate

SMILES

[Na+].[H][C@@]1(OC(=O)C(O)=C1[O-])[C@@H](O)CO

Pharmacology

Indication

Not Available

Associated Therapies

Dietary and Nutritional Therapies

Pharmacodynamics

Not Available

Mechanism of action

Not Available

Unlock Additional Data

Additional Data Available

Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more

Additional Data Available

Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more

Additional Data Available

Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more

Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism

Not Available

Route of elimination

Not Available

Half life

Not Available

Clearance

Not Available

Toxicity

Not Available

Affected organisms

Not Available

Pathways

Not Available

Pharmacogenomic Effects/ADRs

Not Available

Interactions

Drug Interactions

This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.

Drug	Interaction
Unlock Additional Data
2,5-Dimethoxy-4-ethylamphetamine	The serum concentration of 2,5-Dimethoxy-4-ethylamphetamine can be decreased when it is combined with Sodium ascorbate.
2,5-Dimethoxy-4-ethylthioamphetamine	The serum concentration of 2,5-Dimethoxy-4-ethylthioamphetamine can be decreased when it is combined with Sodium ascorbate.
4-Bromo-2,5-dimethoxyamphetamine	The serum concentration of 4-Bromo-2,5-dimethoxyamphetamine can be decreased when it is combined with Sodium ascorbate.
Acetazolamide	The risk or severity of adverse effects can be increased when Acetazolamide is combined with Sodium ascorbate.
Aclidinium	The therapeutic efficacy of Sodium ascorbate can be decreased when used in combination with Aclidinium.
Agmatine	The therapeutic efficacy of Sodium ascorbate can be decreased when used in combination with Agmatine.
Alcuronium	The therapeutic efficacy of Sodium ascorbate can be decreased when used in combination with Alcuronium.
Alfentanil	The therapeutic efficacy of Sodium ascorbate can be decreased when used in combination with Alfentanil.
Alloin	The risk or severity of adverse effects can be increased when Sodium ascorbate is combined with Alloin.
Almasilate	The therapeutic efficacy of Sodium ascorbate can be decreased when used in combination with Almasilate.

Additional Data Available

Extended Description

Extended description of the mechanism of action and particular properties of each drug interaction.

Learn more

Severity

A severity rating for each drug interaction, from minor to major.

Learn more

Evidence Level

A rating for the strength of the evidence supporting each drug interaction.

Learn more

Action

An effect category for each drug interaction. Know how this interaction affects the subject drug.

Learn more

Food Interactions

No interactions found.

References

General References

Not Available

External Links

KEGG Drug: D05853
ChemSpider: 16736174
ChEBI: 113451
ChEMBL: CHEMBL591665
PharmGKB: PA166163262
Wikipedia: Sodium_ascorbate

AHFS Codes

88:12.00 — Vitamin C

Clinical Trials

Clinical Trials

Phase	Status	Purpose	Conditions	Count
1	Completed	Treatment	Colorectal Cancers	1
1	Completed	Treatment	Gastric Emptying / Healthy Volunteers	1
1	Not Yet Recruiting	Treatment	Pharmacokinetics	1
1, 2	Completed	Treatment	Autism Spectrum Conditions/Disorders / Gastrointestinal Problems	1
2	Completed	Diagnostic	Malignant Neoplasm of Colon	1
2	Completed	Other	Bowel preparation therapy	1
2	Completed	Other	Colon Prep for Colonoscopy	1
2	Completed	Treatment	Colonoscopy	1
2	Completed	Treatment	Malignant Neoplasm of Colon	1
2	Recruiting	Treatment	Autism Spectrum Conditions/Disorders / Gastrointestinal Disorder	1
3	Completed	Diagnostic	Patients Who Receive Colonoscopy	1
3	Completed	Screening	Carcinoma, Colorectal / Colon Cleansing / Colorectal Cancers	1
3	Completed	Supportive Care	Colonic Diseases / Diabetes Mellitus	1
3	Completed	Treatment	Bowel Preparation Prior to Endoscopic, Radiological and Other Examinations as Well as to Surgical Procedures Which Require Empty Bowel	1
3	Completed	Treatment	Colon Diseases / Colonoscopy Preparation	1
3	Completed	Treatment	Colonoscopy	3
4	Active Not Recruiting	Diagnostic	Colon Adenomas / Colon Lesion / Colon Polyps	1
4	Completed	Not Available	Colonoscopy	1
4	Completed	Basic Science	Functional Constipation / Irritable Bowel Syndrome Characterized by Constipation	1
4	Completed	Screening	Colorectal Cancers	1
4	Completed	Treatment	Bowel Preparation for Colonoscopy	1
4	Completed	Treatment	Colon Cleansing for Colonoscopy	1
4	Completed	Treatment	Colonoscopy	1
4	Completed	Treatment	Colorectal Cleansing Prior Operation	1
4	Completed	Treatment	Gastrointestinal Diseases	1
4	Not Yet Recruiting	Supportive Care	Colorectal Cancers	1
4	Recruiting	Diagnostic	Ulcerative Colitis	1
Not Available	Completed	Not Available	Hyponatremia	1
Not Available	Recruiting	Diagnostic	Colonoscopy	1
Not Available	Recruiting	Diagnostic	Colorectal Disorders	1
Not Available	Unknown Status	Diagnostic	Colonic Adenomas	1
Not Available	Withdrawn	Screening	Patients Undergoing Screening or Surveillance Colonoscopy	1

Pharmacoeconomics

Manufacturers

Not Available

Packagers

Not Available

Dosage forms

Form	Route	Strength
Wafer	Oral
Solution	Intravenous
Kit	Oral
Powder, for solution	Oral
Tablet, chewable	Oral
Tablet	Oral
Tablet, film coated	Oral
Kit	Intravenous
Tablet	Oral
Liquid	Oral
Powder	Oral
Capsule, gelatin coated	Oral
Powder	Oral
Capsule	Oral
Tablet, coated	Oral
Liquid	Intramuscular; Intravenous	250 mg
Lozenge	Oral

Prices

Not Available

Patents

Patent Number	Pediatric Extension	Approved	Expires (estimated)
Unlock Additional Data
US7169381	No	2007-01-30	2024-09-01
US7658914	No	2010-02-09	2024-09-01
US9326969	No	2016-05-03	2033-09-10
US9592252	No	2017-03-14	2032-08-11
US9707297	No	2017-07-18	2033-09-10
US8999313	No	2015-04-07	2033-09-10
US10016504	No	2018-07-10	2033-09-10

Additional Data Available

Filed On

The date on which a patent was filed with the relevant government.

Learn more

Properties

State

Not Available

Experimental Properties

Not Available

Predicted Properties

Property	Value	Source
Water Solubility	625.0 mg/mL	ALOGPS
logP	-1.4	ALOGPS
logP	-1.9	ChemAxon
logS	0.5	ALOGPS
pKa (Strongest Acidic)	4.36	ChemAxon
pKa (Strongest Basic)	-3	ChemAxon
Physiological Charge	-1	ChemAxon
Hydrogen Acceptor Count	5	ChemAxon
Hydrogen Donor Count	3	ChemAxon
Polar Surface Area	110.05 Å²	ChemAxon
Rotatable Bond Count	2	ChemAxon
Refractivity	47.58 m³·mol^-1	ChemAxon
Polarizability	14.51 Å³	ChemAxon
Number of Rings	1	ChemAxon
Bioavailability	1	ChemAxon
Rule of Five	Yes	ChemAxon
Ghose Filter	No	ChemAxon
Veber's Rule	No	ChemAxon
MDDR-like Rule	No	ChemAxon

Predicted ADMET features

Not Available

Spectra

Mass Spec (NIST): Not Available
Spectra: Not Available

Taxonomy

Description: This compound belongs to the class of organic compounds known as butenolides. These are dihydrofurans with a carbonyl group at the C2 carbon atom.
Kingdom: Organic compounds
Super Class: Organoheterocyclic compounds
Class: Dihydrofurans
Sub Class: Furanones
Direct Parent: Butenolides
Alternative Parents: Vinylogous acids / Enoate esters / Secondary alcohols / Lactones / 1,2-diols / Oxacyclic compounds / Monocarboxylic acids and derivatives / Primary alcohols / Organic zwitterions / Organic sodium salts
show 3 more
Substituents: 2-furanone / Enoate ester / Alpha,beta-unsaturated carboxylic ester / Vinylogous acid / 1,2-diol / Carboxylic acid ester / Lactone / Secondary alcohol / Monocarboxylic acid or derivatives / Carboxylic acid derivative
show 13 more
Molecular Framework: Aliphatic heteromonocyclic compounds
External Descriptors: Not Available

Drug created on July 06, 2018 16:02 / Updated on June 04, 2020 15:41

Sodium ascorbate

Identification

Structure for Sodium ascorbate (DB14482)

Pharmacology

Interactions

References

Clinical Trials

Pharmacoeconomics

Properties

Spectra

Taxonomy